Gender differences in the use of anxiolytics and antidepressants: A population based study

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 11, 2009, Pages 1101-1110

  Van Der Heyden, J H A ^a   Gisle, L ^a   Hesse, E ^a   Demarest, S ^a   Drieskens, S ^a   Tafforeau, J ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Antidepressants; Anxiolytics; Appropriate use; Gender differences; Mental health

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ASSESSMENT; DEPRESSION; DRUG INDICATION; DRUG USE; FEMALE; HEALTH STATUS; HUMAN; INTERVIEW; LIFESTYLE; MALE; MENTAL HEALTH; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SLEEP DISORDER; SOCIAL STATUS;

ADOLESCENT; ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BELGIUM; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MENTAL HEALTH; MIDDLE AGED; POPULATION SURVEILLANCE; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 70549111659     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1827     Document Type: Article

References (47)

1. Alonso J, Angermeyer MC, Lepine JP. The European Study of the Epidemiology of Mental Disorders (ESEMeD) project: an epidemiological basis for informing mental health policies in Europe. Acta Psychiatr Scand Suppl 2004; 420: 5-7. (Pubitemid 38686191)
2. Alonso J, Angermeyer MC, Bernert S, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 420: 55-64. (Pubitemid 38686197)
3. Baumann M, Pommier J, Deschamps JP. Medical prescription and consumption of psychotropic drugs: questions on the differences between men and women. Cah Sociol Demogr Med 1996; 36: 63-78.
4. Cafferata GL, Meyers SM. Pathways to psychotropic drugs. Understanding the basis of gender differences. Med Care 1990; 28: 285-300.
5. Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 420: 21-27. (Pubitemid 38686193)
6. WHO. How to Develop and Implement a National Drug Polidy (2nd edn). World Health Organisation: Geneva, 2001.
7. Fraser AD. Use and abuse of the benzodiazepines. Ther Drug Monit 1998; 20: 481-489.
8. O'brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 2005; 66 (Suppl 2): 28-33.
9. Jureidini J, Tonkin A. Overuse of antidepressant drugs for the treatment of depression. CNS Drugs 2006; 20: 623-632. (Pubitemid 44141490)
10. Sheehan DV. Depression: underdiagnosed, undertreated, underappreciated. Manag Care 2004; 13: 6-8.
11. Batty GM, Oborne CA, Swift CG, et al. Development of an indicator to identify inappropriate use of benzodiazepines in elderly medical inpatients. Int J Geriatr Psychiatry 2000; 15: 892-896.
12. Howard M, Dolovich L, Kaczorowski J, et al. Prescribing of potentially inappropriate medications to elderly people. Fam Pract 2004; 21: 244-247. (Pubitemid 38765297)
13. Mort JR, Aparasu RR. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med 2000; 160: 2825-2831.
14. Van Oyen H, Tafforeau J, Hermans H, et al., The Belgian Health Interview Survey. Arch Public Health 1997; 55: 1-13. http://www.iph.fgov.be/aph/pdf/ aphfull55-1-13.pdf.
15. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. WHO Collaborating Centre for Drug Statistics Methodology: Oslo, 2000; 7-268.
16. Derogatis LR. SCL-90-R Administration, Scoring and Procedures Manual. National Computer System: Minneapolis, 1994; 1-123.
17. Levecque K, Schotte C. Validiteit en betrouwbaarheid van de SCL angst-en depressieschaal in de algemene bevolking in België. Tijdschr Klin Psychol 2006; 36: 44-60.
18. Levecque K, Lodewyckx I, Vranken J. Depression and generalised anxiety in the general population in Belgium: a comparison between native and immigrant groups. J Affect Disord 2007; 97: 229-239. (Pubitemid 44940820)
19. de Bruin A, Picavet HS, Nosikov A. Health Interview Surveys: Towards International Harmonization of Methods and Instruments. World Health Organisation: Copenhagen, 1996; 1-161.
20. Picavet HS, van den Bos GA. The contribution of six chronic conditions to the total burden of mobility disability in the Dutch population. Am J Public Health 1997; 87: 1680-1682.
21. Sherbourne CD, Stewart AL. The MOS Social Support Survey. Soc Sci Med 1991; 32: 705-714.
22. Hagenaars A, de Vos K, Zaïdi MA. Comparison Between Poverty Rates in Wave 1 ECHP for 1993. Office for Official Publications of the European Communities: Luxembourg, 2001.
23. Kunst AE, Mackenbach JP. Measuring Socio-Economic Inequalities in Health. EUR/ICP/RPD 416. WHO Regional Office for Europe: Copenhagen, 1994.
24. StataCorp. Stata Statistical Software: Release 10. StataCorp: College Station, TX, 2007.
25. Berchtold A. Key elements in the statistical analysis of surveys. Int J Public Health 2007; 52: 117-119. (Pubitemid 46767621)
26. Soegaard AJ, Selmer R, Bjertness E, et al. The Oslo Health Study: the impact of self-selection in a large, population based survey. Intern J Equity Health 2004; 3: 1-28. (Pubitemid 38783196)
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn). American Psychiatric Association: Washington DC, 2000.
28. Bruffaerts R, Bonnewyn A, Van Oyen H, et al. Patterns of service use for mental health disorders in Belgium. Results of the European Study on Epidemiology of Mental Disorders (ESEMeD). Rev Med Liege 2004; 59: 136-144. (Pubitemid 38529259)
29. de Girolamo G, Polidori G, Morosini P, et al. Prevalence of common mental disorders in Italy: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). Soc Psychiatry Psychiatr Epidemiol 2006; 41: 853-861.
30. Haro JM, Palacin C, Vilagut G, et al. Prevalence of mental disorders and associated factors: results from the ESEMeD-Spain study. Med Clin (Barc) 2006; 126: 445-451.
31. Lepine JP, Gasquet I, Kovess V, et al. Prevalence and comorbidity of psychiatric disorders in the French general population. Encephale 2005; 31: 182-194. (Pubitemid 40675702)
32. Piccinelli M, Wilkinson G. Gender differences in depression. Critical review. Br J Psychiatry 2000; 177: 486-492. (Pubitemid 32005477)
33. Pigott TA. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry 1999; 60 (Suppl 18): 4-15. (Pubitemid 29431907)
34. Fankhauser MP. Psychiatric disorders in women: psychopharmacologic treatments. J Am Pharm Assoc (Wash) 1997; NS37: 667-678.
35. Briscoe ME, Vazquez-Barquero JL,Williams P, et al. Sex differences in the differentiation of psychiatric symptomatology. Br J Psychiatry 1989; 154: 364-367.
36. van der Waals FW, Mohrs J, Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. Br Med J 1993; 307: 363-366.
37. Morabia A, Fabre J, Dunand JP. The influence of patient and physician gender on prescription of psychotropic drugs. J Clin Epidemiol 1992; 45: 111-116.
38. Hohmann AA. Gender bias in psychotropic drug prescribing in primary care. Med Care 1989; 27: 478-490.
39. Ashton H. Psychotropic-drug prescribing for women. Br J Psychiatry Suppl 1991; 30-35.
40. Pihl RO, Murdoch D, Lapp JE, et al. Psychotrope and alcohol use by women: one or two populations? J Clin Psychol 1986; 42: 991-999.
41. Mazza D, Dennerstein L. Psychotropic drug use by women: could violence account for the gender difference? J Psychosom Obstet Gynaecol 1996; 17: 229-234.
42. Gorman JM. Gender differences in depression and response to psychotropic medication. Gend Med 2006; 3: 93-109. (Pubitemid 44057819)
43. Pollack MH. Comorbid anxiety and depression. J Clin Psychiatry 2005; 66 (Suppl 8): 22-29.
44. Fourrier A, Letenneur L, Dartigues JF, et al. Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol 2001; 57: 419-425. (Pubitemid 33787193)
45. Lechevallier N, Fourrier A, Berr C. Benzodiazepine use in the elderly: the EVA Study. Rev Epidemiol Sante Publique 2003; 51: 317-326. (Pubitemid 37033679)
46. Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998; 13: 243-250. (Pubitemid 28169437)
47. Johnell K, Fastbom J, Rosen M, et al. Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother 2007; 41: 1243-1248. (Pubitemid 47122563)